There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Chimerix (CMRX – Research Report), Rani Therapeutics Holdings (RANI – Research Report) and Autolus Therapeutics (AUTL – Research Report) with bullish sentiments.
Chimerix (CMRX)
JonesTrading analyst Soumit Roy maintained a Buy rating on Chimerix today and set a price target of $5.00. The company’s shares closed last Thursday at $0.95, close to its 52-week low of $0.92.
According to TipRanks.com, Roy has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on Chimerix is a Strong Buy with an average price target of $7.75, which is a 724.9% upside from current levels. In a report released today, TD Cowen also maintained a Buy rating on the stock with a $8.00 price target.
See today’s best-performing stocks on TipRanks >>
Rani Therapeutics Holdings (RANI)
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Rani Therapeutics Holdings today and set a price target of $20.00. The company’s shares closed last Thursday at $1.84.
According to TipRanks.com, Kapoor is ranked 0 out of 5 stars with an average return of
Rani Therapeutics Holdings has an analyst consensus of Strong Buy, with a price target consensus of $20.25, which is a 930.5% upside from current levels. In a report released yesterday, BTIG also assigned a Buy rating to the stock with a $24.00 price target.
Autolus Therapeutics (AUTL)
Needham analyst Gil Blum maintained a Buy rating on Autolus Therapeutics today and set a price target of $7.00. The company’s shares closed last Thursday at $3.35, close to its 52-week high of $3.53.
According to TipRanks.com, Blum is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Autolus Therapeutics is a Strong Buy with an average price target of $8.50, a 192.1% upside from current levels. In a report issued on October 24, Wells Fargo also maintained a Buy rating on the stock with a $6.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CMRX:
